Apply now to join this meeting in Brussels, Belgium
Application deadline: 23 July 2015
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
ESMO’s flagship scientific journal, Annals of Oncology, publishes editorials, reviews, original articles and letters related to oncology
OncologyPRO, a 360° information hub designed around YOU, is your single gateway to essential knowledge & resources
As part of our 40th Anniversary celebrations we are highlighting the knowledge transfer & networking experiences that are made possible each year by ESMO fellowships. Angela Lamarca and Emanuele Zucca explain these career-changing moments and the profound effect upon their professional paths.
07 Jul 2015
It is a generic of Taxotere, which has been authorised in the EU since 1995
06 Jul 2015
The first of the 2015 ESMO Clinical Practice Guidelines is now online!
04 Jul 2015
Patients with metastatic colorectal cancer (mCRC) that are mutation-free in the KRAS, NRAS, BRAF and PIK3CA genes showed significant benefit from...
03 Jul 2015
Researchers announced that the phase IIIb CONSIGN study has confirmed the benefit, with safety profile and progression free survival similar to phase...
01 Jul 2015
The multicentre, open label, randomised phase III trial evaluated the NK1 antagonist aprepitant for the prevention of nausea and vomiting induced by...
01 Jul 2015
A total of 6,128 patients were included in the analysis, which showed that patients with the lowest BMI had a significantly shorter overall survival...
Oxford, United Kingdom
28 Aug - 30 Aug 2015
25 Sep - 29 Sep 2015
23 Oct - 24 Oct 2015
Miami, Florida, United States of America
06 Nov - 08 Nov 2015
12 Nov - 15 Nov 2015
20 Nov - 21 Nov 2015